PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 41st Annual J.P. Morgan Healthcare Conference ...Middle East

- ~$710 million unaudited 2022 total revenue, representing an impressive over 30% year-over-year growth – - $940 million - $1.0 billion 2023 total revenue guidance – - Results from three registration-directed clinical trials expected in 2023 – - One additional registration-directed...

Hence then, the article about ptc therapeutics provides an update on commercial progress and r d pipeline at 41st annual j p morgan healthcare conference was published today ( Monday 09/01/2023 - 05:28 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 41st Annual J.P. Morgan Healthcare Conference )

Also on site :

• Walmart's 'Cute' $210 Striped Linen Swivel Accent Chair Adds Cozy Farmhouse Vibes to Any Space
• UN welcomes ceasefire announced by Ukraine, Russia
• 'You Can't Think of the Negatives': 'Love on the Spectrum' Star Tyler White Opens Up About Autism and Music